https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-successful-us-fda-type-c-meeting-on-j9nv9004jjro.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-announces-successful-us-fda-type-c-meeting-on-j9nv9004jjro.html?utm_source=stocktitan-bluesky&utm_medium=social
#$IDYA drew $8,024 in options premium: calls $7,584, puts $440 (95% calls).
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
#$IDYA drew $8,024 in options premium: calls $7,584, puts $440 (95% calls).
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
Full story (not investment advice): https://www.merlintrader.com/ideaya-biosciences-stock-hub/
Full story (not investment advice): https://www.merlintrader.com/ideaya-biosciences-stock-hub/
Hub: https://www.merlintrader.com/ideaya-biosciences-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=flyer-q3-2026&utm_content=idya
Not investment advice.
Hub: https://www.merlintrader.com/ideaya-biosciences-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=flyer-q3-2026&utm_content=idya
Not investment advice.
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
IDYA Stock Hub: IDEAYA Biosciences News, Darovasertib and Precision Oncology
www.merlintrader.com/ideaya-biosc...
IDYA Stock Hub: IDEAYA Biosciences News, Darovasertib and Precision Oncology
www.merlintrader.com/ideaya-biosc...
$1.15B in cash and securities at Sep 30; runway guidance into 2030 unchanged.
Mon close $31.64: below SMA50, below SMA200, RSI 34.
Hub: www.merlintrader.com/ideaya-biosc...
Not investment advice.
$1.15B in cash and securities at Sep 30; runway guidance into 2030 unchanged.
Mon close $31.64: below SMA50, below SMA200, RSI 34.
Hub: www.merlintrader.com/ideaya-biosc...
Not investment advice.
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-november-2026-investor-brqtyi0n8nnw.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-to-participate-in-upcoming-november-2026-investor-brqtyi0n8nnw.html?utm_source=stocktitan-bluesky&utm_medium=social
Phase 3 OptimUM-010 Trial Enrollment Stopped and Trial Closed
Due to site activation and enrollment challenges, IDEAYA stopped enrollment and closed the Phase 3 OptimUM-010 neoadjuvant darovasertib trial. Expected cost savings of $…
https://biostock.app/symbols/IDYA
Phase 3 OptimUM-010 Trial Enrollment Stopped and Trial Closed
Due to site activation and enrollment challenges, IDEAYA stopped enrollment and closed the Phase 3 OptimUM-010 neoadjuvant darovasertib trial. Expected cost savings of $…
https://biostock.app/symbols/IDYA
https://fundspec.ai/s/IDYA/earnings
Know who reports today, with an AI probability of a beat or a miss.
https://fundspec.ai/s/IDYA/earnings
Know who reports today, with an AI probability of a beat or a miss.
On November 3, 2026, IDEAYA Biosciences, Inc. announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in t...
On November 3, 2026, IDEAYA Biosciences, Inc. announced its financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in t...
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-reports-financial-results-for-the-third-quarter-rt12rz71ur26.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-reports-financial-results-for-the-third-quarter-rt12rz71ur26.html?utm_source=stocktitan-bluesky&utm_medium=social
IDYA Stock Hub: IDEAYA Biosciences News, Darovasertib and Precision Oncology
www.merlintrader.com/ideaya-biosc...
IDYA Stock Hub: IDEAYA Biosciences News, Darovasertib and Precision Oncology
www.merlintrader.com/ideaya-biosc...
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#IDYA
$SPY $XBI. Not investment advice.
Bull/bear scenarios on JC Just Charts: https://justcharts.merlintrader.com/#IDYA
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
https://www.stocktitan.net/news/IDYA/ide849-shr-4849-dll3-top1-adc-updated-phase-1-results-at-esmo-2026-mb8r58o67ka9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IDYA/ide849-shr-4849-dll3-top1-adc-updated-phase-1-results-at-esmo-2026-mb8r58o67ka9.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
https://www.merlintrader.com/ideaya-biosciences-stock-hub/
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-and-servier-announce-data-from-three-clinical-njac7n805z9y.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/IDYA/ideaya-biosciences-and-servier-announce-data-from-three-clinical-njac7n805z9y.html?utm_source=stocktitan-bluesky&utm_medium=social
October 23–27, 2026 (conference window) — Oncology Clinical Presentations
ESMO presentations on darovasertib, a Phase 2 combination and IDE849; individual dates not set.
🔗 Full details: www.merlintrader.com/ideaya-biosc...
#IDYA #Biotech #ESMO2026
October 23–27, 2026 (conference window) — Oncology Clinical Presentations
ESMO presentations on darovasertib, a Phase 2 combination and IDE849; individual dates not set.
🔗 Full details: www.merlintrader.com/ideaya-biosc...
#IDYA #Biotech #ESMO2026